UpTempo (SM) CAR-T Cell Platform: a Flexible, Modular Process to Speed your Path to Patients
Time: 12:00 pm
day: Day 1 - Track C - AM
Details:
- Catalent’s fully closed GMP compliant CAR-T cell platform enables your cell therapy to reach the clinic and patients faster.
- Data-driven guidance to build a seamless, robust, modular workflow for both autologous and allogeneic cell therapies. Minimize risk without compromising on quality.
- With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service CDMO partner for cell therapy. We offer flexible and transparent customer care
